However, whether EA improves the comorbidity of visceral pain and depression in IBD mice by regulating P2Y12 expression in the mPFC remains unknown, which severely hinders the clinical practice of EA in treating IBD. This evidence concerns the gene P2RY12 and depressive symptom measurement.